The National Cancer Institute (NCI) awarded a $1,043,109 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Isono Health, Inc. The goal of this 2-year project is to develop and validate Artificial Intelligence (AI) models for Isono Health's ATUSA imaging platform, which is designed to provide automated 3D breast ultrasound screening for early breast cancer detection. The ATUSA platform includes a wearable imaging device that can rapidly scan the entire breast, combined with AI algorithms to identify and diagnose breast cancer at an early stage. This project will establish baseline diagnostic performance measures for the ATUSA system's lesion classification, lesion segmentation, and breast density calculation capabilities. The successful completion of this project will enable Isono Health to seek FDA clearance for the AI-powered ATUSA system and commercially launch the product, which aims to increase access to supplemental breast imaging and timely breast cancer diagnosis, particularly for underserved populations.
Generated 2/25/25, 3:32 AM